BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 30963302)

  • 1. Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.
    Yang F; Ma L; Zhang L; Wang Y; Zhao C; Zhu W; Liang W; Liu Q
    Heart Vessels; 2019 Oct; 34(10):1608-1614. PubMed ID: 30963302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the serum lipoprotein-associated phospholipase A
    Dong L; Tong J; Fan S
    Cardiovasc J Afr; 2023 Nov-Dec 23; 34(5):273-277. PubMed ID: 36637451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change of Inflammatory Factors in Patients with Acute Coronary Syndrome.
    Ma CY; Xu ZY; Wang SP; Peng HY; Liu F; Liu JH; Ren FX
    Chin Med J (Engl); 2018 Jun; 131(12):1444-1449. PubMed ID: 29893361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-Associated Phospholipase A2 in Cardiac Disease: a Potential Early Biomarker of Unstable Coronary Artery Disease.
    Li J; Zhou Z; Niu X; Li H
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II).
    Möckel M; Müller R; Vollert J; Müller C; Danne O; Gareis R; Störk T; Dietz R; Koenig W
    Clin Res Cardiol; 2007 Sep; 96(9):604-12. PubMed ID: 17593313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosis.
    Verdoia M; Rolla R; Gioscia R; Rognoni A; De Luca G;
    J Thromb Thrombolysis; 2023 Jul; 56(1):37-44. PubMed ID: 37022507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Lipoprotein-Associated Phospholipase A2 Level Is an Independent Predictor of High Thrombus Burden in Patients With Acute ST-segment Elevation Myocardial Infarction.
    Wu X; Zhang Y; Wu Z; You W; Liang F; Ye F; Chen S
    Int Heart J; 2016 Dec; 57(6):689-696. PubMed ID: 27818473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z
    Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a community-based cohort.
    Li N; Li S; Yu C; Gu S
    Postgrad Med; 2010 Jul; 122(4):200-5. PubMed ID: 20675983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pentraxin-3 and ischemia-modified albumin with troponin in early diagnosis of acute coronary syndrome.
    Demir MT; Baydin A; Amanvermez R; Erenler AK; Güzel M; Yücel O
    Bratisl Lek Listy; 2018; 119(8):509-512. PubMed ID: 30160160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndrome.
    Li J; Wang H; Tian J; Chen B; Du F
    Medicine (Baltimore); 2018 Jul; 97(28):e11517. PubMed ID: 29995820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship Between the Level of Serum ESM-1 and Lp-PLA2 in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    Wei P; Zong B; Liu X; Zhang M; Yang C; Wang H; Fu Q; Wang L; Cao B
    Clin Transl Sci; 2021 Jan; 14(1):179-183. PubMed ID: 32710501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris.
    Wudkowska A; Goch J; Goch A
    Kardiol Pol; 2010 Apr; 68(4):431-7. PubMed ID: 20425705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of serum lipoprotein-associated phospholipase A2, ischemia-modified albumin, and cystatin C in predicting coronary heart disease risk: a single center retrospective cohort study.
    Le QF; Liu J; Chen L
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10730-10735. PubMed ID: 37975398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is lipoprotein-associated phospholipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome?
    Gu X; Hou J; Yang S; Yu H; Tian J; Liu F; Li N; Yu B; Jang IK
    Coron Artery Dis; 2014 Jan; 25(1):10-5. PubMed ID: 24089018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoprotein-associated phospholipase A2 mass is elevated in STEMI compared to non-STEMI patients but does not discriminate between myocardial infarction and non-cardiac chest pain.
    Dullaart RP; van Pelt LJ; Kwakernaak AJ; Dikkeschei BD; van der Horst IC; Tio RA
    Clin Chim Acta; 2013 Sep; 424():136-40. PubMed ID: 23756128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
    Cai A; Li G; Chen J; Li X; Li L; Zhou Y
    BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
    Zhang H; Gao Y; Wu D; Zhang D
    BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome.
    Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Ohkawa R; Nakamura K; Yanagisawa N; Tsuboi S; Ogita M; Yokoyama K; Kurata T; Yatomi Y; Daida H
    Atherosclerosis; 2011 Dec; 219(2):907-12. PubMed ID: 22024276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.